At a glance
- Originator N. S. Kurnakov Institute of General and Inorganic Chemistry
- Developer N. S. Kurnakov Institute of General and Inorganic Chemistry; Nonindustrial source
- Class Antineoplastics; Platinum complexes; Small molecules
- Mechanism of Action Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Solid tumours
Most Recent Events
- 28 Nov 2000 No-Development-Reported for Solid tumours in Russia (Unknown route)
- 09 May 1995 Phase-II clinical trials for Solid tumours in Russia (Unknown route)
- 04 May 1995 Preclinical development for Cancer in Germany (Unknown route)